1
|
Strisciuglio T, El Haddad M, Debonnaire P, De Pooter J, Demolder A, Wolf M, Phlips T, Kyriakopoulou M, Almorad A, Knecht S, Tavernier R, Vandekerckhove Y, Duytschaever M. Paroxysmal atrial fibrillation with high vs. low arrhythmia burden: atrial remodelling and ablation outcome. Europace 2021; 22:1189-1196. [PMID: 32601674 DOI: 10.1093/europace/euaa071] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2019] [Accepted: 03/11/2020] [Indexed: 11/13/2022] Open
Abstract
AIMS The relation between atrial tachyarrhythmia (ATA) burden in paroxysmal atrial fibrillation (AF), atrial remodelling, and efficacy of catheter ablation (CA) is unknown. We investigated whether high vs. low-burden paroxysmal AF patients have distinct clinical characteristics or electro-mechanical properties of the left atrium (LA) and whether burden impacts outcome of CA. METHODS AND RESULTS Atrial tachyarrhythmia burden, defined as the percentage of time spent in ATA, was assessed by insertable cardiac monitors in 105 patients before and after CA. Clinical characteristics and electro-mechanical properties of LA were compared between patients with high vs. low ATA burden. Catheter ablation efficacy was assessed by reduction in ATA burden and 1-year freedom from any ATA. Median ATA burden was 2.7% (highest tertile 9.3%). Clinical characteristics and electrical properties of LA (refractoriness, conduction velocity, low voltage) did not differ between high (≥9.3%) vs. low ATA burden (<9.3%) patients. High ATA burden patients had larger LA diameter (46.5 ± 6 vs. 42.5 ± 6mm, P < 0.01), volume (93.8 ± 22 vs. 80.4 ± 21mL, P = 0.01), and lower LA reservoir and contractile strain (19.7 ± 6 vs. 24.7 ± 6%, P < 0.01; 10.3 ± 3 vs. 12.8 ± 4%, P = 0.01). Catheter ablation reduced ATA burden by 100% (100-100) in both groups (P = 1.0). Freedom from ATA after CA was equally high (83% vs. 89%, P = 0.38). CONCLUSION Paroxysmal AF patients with high ATA burden have altered LA mechanical properties, reflected by larger size and impaired function. Despite mechanical remodelling of the atria, they are excellent responders to CA. Most likely the lack of fibrosis and/or advanced electrical remodelling explain why pulmonary veins remain the dominant trigger for AF in this patient cohort.
Collapse
Affiliation(s)
- T Strisciuglio
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium.,Department of Advanced Biomedical Sciences, University of Naples Federico II, Italy
| | - M El Haddad
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - P Debonnaire
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - J De Pooter
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium.,Ghent University Hospital, Heart Center, De Pintelaan 185, 9000 Ghent, Belgium
| | - Anthony Demolder
- Ghent University Hospital, Heart Center, De Pintelaan 185, 9000 Ghent, Belgium
| | - M Wolf
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - T Phlips
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - M Kyriakopoulou
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - A Almorad
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - S Knecht
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - R Tavernier
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - Y Vandekerckhove
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium
| | - Mattias Duytschaever
- Department of Cardiology, Sint-Jan Hospital, Ruddershove 10, 8000 Bruges, Belgium.,Ghent University Hospital, Heart Center, De Pintelaan 185, 9000 Ghent, Belgium
| |
Collapse
|
2
|
De Clercq D, Decloedt A, Tavernier R, Deprez P, Van Loon G. Atrial and ventricular electrical and contractile remodelling and reverse remodelling due to chronic pacing-induced atrial fibrillation in horses: preliminary results. VLAAMS DIERGEN TIJDS 2019. [DOI: 10.21825/vdt.v88i5.15999] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
In humans, electrical and contractile reverse remodelling following restoration of sinus rhythm (SR) after a prolonged period of spontaneous atrial fibrillation (AF), requires several weeks. There is little known about this phenomenon in horses. In the present study, six healthy horses were instrumented with a neurostimulator and a pacemaker to maintain AF for four months by intermittent burst pacing and to study atrial and ventricular electrophysiology. AF became persistent in all horses after two to six weeks of burst pacing. Before, during and after the AF period, parameters, such as the atrial fibrillation cycle length, the right atrial and ventricular refractory period and vulnerability, such as inducing atrial arrythmias, atrial tachyarrythmias or maintaining AF, were determined. Two-dimensional echocardiography was used to measure atrial and ventricular contractility expressed as fractional shortening and size expressed as diameter and area. In two of the six horses, the procedure was discontinued due to an increased threshold (1 horse) and due to infection at the level of the pacemaker pocket (1 horse). In the four remaining horses, significant electrical and contractile remodelling compared to baseline values was observed from 48 hours onwards after AF induction. Upon restoration of SR with quindine sulfate, all electrical and contractile values returned to normal within one to two months. No ventricular remodelling was observed. Four months of pacing-induced AF resulted in electrical and contractile remodelling and reverse remodelling. The results suggest that pacing-induced chronic AF does not cause permanent damage and suggest that a resting period of six to eight weeks before returning to training might be beneficial.
Collapse
|
3
|
Fedida J, Strisciuglio T, Sohal M, Wolf M, Vanbeeumen K, Neyrinck A, Taghji P, Lepiece C, Vandekerckhove Y, Tavernier R, Duytschaever M, Knecht S. Efficacy of advanced pace mapping technology for idiopathic premature ventricular complexes ablation: Usefulness of pace mapping. Archives of Cardiovascular Diseases Supplements 2019. [DOI: 10.1016/j.acvdsp.2018.10.179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
4
|
De Pooter J, El Haddad M, Striscuiglio T, Wolf M, Phlips T, Tavernier R, Knecht S, Vandekerckhove Y, Duytschaever M. P849Recurrence of atrial fibrillation after CLOSE-guided pulmonary vein isolation: observations at repeat ablation and follow-up. Europace 2018. [DOI: 10.1093/europace/euy015.452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- J De Pooter
- Ghent University Hospital (UZ), Heart Center, Ghent, Belgium
| | - M El Haddad
- Ghent University Hospital (UZ), Heart Center, Ghent, Belgium
| | | | - M Wolf
- St-Jan Hospital, Cardiology, Bruges, Belgium
| | - T Phlips
- St-Jan Hospital, Cardiology, Bruges, Belgium
| | - R Tavernier
- St-Jan Hospital, Cardiology, Bruges, Belgium
| | - S Knecht
- St-Jan Hospital, Cardiology, Bruges, Belgium
| | | | | |
Collapse
|
5
|
Strisciuglio T, Debonnaire P, El Haddad M, De Pooter J, Tavernier R, Knecht S, Vandekerckhove Y, Duytschaever M. P863Atrial fibrillation burden and left atrial imaging. Europace 2018. [DOI: 10.1093/europace/euy015.466] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- T Strisciuglio
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - P Debonnaire
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - M El Haddad
- Ghent University Hospital (UZ), Heart Center, Ghent, Belgium
| | - J De Pooter
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - R Tavernier
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - S Knecht
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | | | - M Duytschaever
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| |
Collapse
|
6
|
Tavernier R, Strisciuglio T, Van Heuverswyn F, Timmers L, De Pooter J, Knecht S, Duytschaever M, Vandekerckhove Y, Kucher A, Stroobandt R. P1229Different scenarios leading to inappropriate therapy inhibition in single chamber ICD detection programming. Europace 2018. [DOI: 10.1093/europace/euy015.710] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- R Tavernier
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - T Strisciuglio
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | | | - L Timmers
- Ghent University Hospital (UZ), Ghent, Belgium
| | - J De Pooter
- Ghent University Hospital (UZ), Ghent, Belgium
| | - S Knecht
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - M Duytschaever
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | | | | | | |
Collapse
|
7
|
Strisciuglio T, El Haddad M, De Pooter J, Bar-Tal M, Tavernier R, Knecht S, Vandekerckhove Y, Duytschaever M. P1153Atrial voltage and conduction velocity in paroxysmal AF without overt structural heart disease: reference values and impact of contact force. Europace 2018. [DOI: 10.1093/europace/euy015.639] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- T Strisciuglio
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - M El Haddad
- Ghent University Hospital (UZ), Heart Center, Ghent, Belgium
| | - J De Pooter
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - M Bar-Tal
- Biosense Webster Inc , Diamond bar, United States of America
| | - R Tavernier
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | - S Knecht
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| | | | - M Duytschaever
- St-Jan Hospital, Department of Cardiology, Bruges, Belgium
| |
Collapse
|
8
|
Fedida J, Strisciuglio T, Sohal M, Wolf M, Van Beeumen K, Neyrinck A, Taghji P, Lepiece C, Almorad A, Vandekerckhove Y, Tavernier R, Duytschaever M, Knecht S. Efficacy of advanced pace-mapping technology for idiopathic premature ventricular complexes ablation. J Interv Card Electrophysiol 2018; 51:271-277. [DOI: 10.1007/s10840-018-0320-8] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/21/2017] [Accepted: 01/25/2018] [Indexed: 11/25/2022]
|
9
|
Fedida J, Sohal M, Wolf M, Van Beeumen K, Neyrinck A, Taghji P, Choudhury R, Louw R, Vandekerkchove Y, Tavernier R, Duytschaever M, Knecht S. P925Efficacy of advanced pace mapping technology for idiopathic pvc ablation. Europace 2017. [DOI: 10.1093/ehjci/eux151.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
10
|
De Pooter J, Elhaddad M, Phlips T, Timmers L, Van Heuverswyn F, Knecht S, Tavernier R, Duytschaever M. P301Comparison of local activation time annotation algorithms in high density mapping of regular atrial tachycardias. Europace 2017. [DOI: 10.1093/ehjci/eux141.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Arbelo E, Brugada J, Hindricks G, Maggioni AP, Tavazzi L, Vardas P, Laroche C, Anselme F, Inama G, Jais P, Kalarus Z, Kautzner J, Lewalter T, Mairesse GH, Perez-Villacastin J, Riahi S, Taborsky M, Theodorakis G, Trines SA, Brugada J, Arbelo E, Hindriks G, Maggioni AP, Morgan J, Tavazzi L, Vardas P, Alonso A, Ferrari R, Komajda M, Tavazzi L, Wood D, Vardas P, Brugada J, Mairesse G, Taborsky M, Kautzner J, Lewalter T, Riahi S, Jais P, Anselme F, Theodorakis G, Inama G, Trines S, Kalarus Z, Villacastin JP, Maggioni AP, Manini M, Gracia G, Laroche C, Missiamenou V, Taylor C, Konte M, Fiorucci E, Lefrancq EF, Glémot M, McNeill PA, Bois T, Heidbüchel H, Nuyens D, Boland J, Dinraths V, Herzet JM, Hoffer E, Malmendier D, Massoz M, Pourbaix S, Ballant E, Blommaert D, Deceuninck O, Dormal F, Xhaet O, De Potter T, Geelen P, Derycker K, Duytschaever M, Tavernier R, Vandekerckhove Y, Vankats D, Bulava A, Hanis J, Sitek D, Blahova M, Cihak R, Hanyasova L, Jansova H, Peichl P, Tanzerova M, Wichterle D, Duda J, Haman L, Parizek P, Coling L, Neuzil P, Petru J, Sediva L, Skoda J, Chovancik J, Fiala M, Neuwirth R, Karlsdottir A, Pehrson S, Gerdes C, Jensen H, Lukac P, Nielsen JC, Hansen J, Johannessen A, Hansen PS, Pedersen A, Heath F, Hjortshoj S, Thogersen A, Da Costa A, Martel I, Romeyer-Bouchard C, Sadki N, Schmid A, Haissaguerre M, Hocini M, Knecht S, Sacher F, Ait Said M, Cauchemez B, Ledoux F, Thomas O, Cebron JP, Decarsin N, Gras D, Hervouet S, Durand C, Durand-Dubief A, Poty H, Babuty D, Pierre B, Albenque JP, Boveda S, Combes N, Mas R, Hermida JS, Kubala M, Godin B, Savouré A, Soublin Y, Defaye P, Jacon P, Brigadeau F, Corbut S, Flament-Balzola F, Kacet S, Klug D, Lacroix D, Copie X, Gilles L, Hocine Z, Paziaud O, Piot O, Crocq C, Kaballu G, Le Moal V, Lotton P, Mabo P, Pavin D, Andronache M, De Chillou C, Magnin-Poull I, Deharo JC, Durand C, Franceschi F, Peyrouse E, Prevot S, Etchegoin M, Extramiana F, Leenhardt A, Messali A, Heine T, Schneider A, Winter N, Brachmann J, Ritscher G, Schertel-Gruenler B, Simon H, Sinha AM, Turschner O, Wystrach A, Stemberg M, Kuck KH, Metzner A, Tilz R, Wissner E, Heitmann K, Willems S, Andresen D, Mueller S, Volkmer M, Schmidt B, Kostopoulou A, Livanis E, Voudris V, Efremidis M, Letsas K, Tsikrikas S, Christoforatou E, Ioannidis P, Katsivas A, Kourouklis S, Andrikopoulos G, Rassias I, Tzeis S, Dakos G, Paraskevaidis S, Stavropoulos G, Theofilogiannakos E, Vassilikos V, Bongiorni M, Zucchelli G, Raviele A, Themistoclakis S, Pratola C, Tritto M, Della Bella P, Mazzone P, Moltrasio M, Tondo C, Calo L, De Luca L, Guarracini F, Lioy E, Dozza L, Frigoli E, Giannelli L, Pappone C, Saviano M, Schiavina G, Vicedomini G, De Ponti R, Doni LA, Marazzi R, Salerno-Uriarte J, Tamborini C, Anselmino M, Ferraris F, Gaita F, Bertaglia E, Brandolino G, Zoppo F, De Groot N, Janse P, Jordaens L, Pison L, Roos C, Van Gelder I, Manusama R, Meijer A, Van der Voort P, Trines S, Compier MG, Kazmierczak J, Kornacewicz-Jach Z, Wielusinski M, Baran J, Kulakowski P, Dzidowski M, Fuglewicz A, Nowak K, Pruszkowska-Skrzep P, Wozniak A, Nowak S, Trusz-Gluza M, Almendral J, Atienza F, Castellanos E, De Diego C, Ortiz M, Moreno Planas J, Perez Castellano N, Benezet J, Farre Muncharaz J, Rubio Campal J, Hernandez Madrid A, Matia R, Arana E, Pedrote A, Cozar R, Peinado R, Valverde I, Arbelo E, Berruezo A, Calvo N, Guiu E, Husseini S, Mont Girbau L. The Atrial Fibrillation Ablation Pilot Study: an European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. Eur Heart J 2014; 35:1466-78. [DOI: 10.1093/eurheartj/ehu001] [Citation(s) in RCA: 151] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Elena Arbelo
- Department of Cardiology, Thorax Institute, Hospital Clínic de Barcelona, C/ Villarroel 170, 6° - Escala 3, 08036, University of Barcelona, Barcelona, Spain
| | - Josep Brugada
- Department of Cardiology, Thorax Institute, Hospital Clínic de Barcelona, C/ Villarroel 170, 6° - Escala 3, 08036, University of Barcelona, Barcelona, Spain
| | | | - Aldo P. Maggioni
- EURObservational Research Programme, European Society of Cardiology, Sophia – Antipolis, France
| | - Luigi Tavazzi
- GVM Care and Research, E.S. Health Science Foundation, Maria Cecilia Hospital, Cotignola, Italy
| | - Panos Vardas
- Department of Cardiology, Heraklion University Hospital, Crete, Greece
| | - Cécile Laroche
- EURObservational Research Programme, European Society of Cardiology, Sophia – Antipolis, France
| | - Frédéric Anselme
- Service De Cardiologie, Hôpital Charles Nicolle, Rouen Cedex, France
| | | | - Pierre Jais
- Hôpital Cardiologique du Haut-Lévêque, Bordeaux-Pessac, France
| | - Zbigniew Kalarus
- Department of Cardiology, Silesian Academy of Medicine, Zabrze, Poland
| | - Josef Kautzner
- Department of Cardiology, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic
| | | | | | | | - Sam Riahi
- AF Study Group, Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
| | - Milos Taborsky
- Internal Cardiology Department, Faculty Hospital Olomouc, Olomouc, Czech Republic
| | | | - Serge A. Trines
- Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
12
|
De Greef Y, Buysschaert I, Schwagten B, Stockman D, Tavernier R, Duytschaever M. Duty-cycled multi-electrode radiofrequency vs. conventional irrigated point-by-point radiofrequency ablation for recurrent atrial fibrillation: comparative 3-year data. Europace 2014; 16:820-5. [PMID: 24443035 DOI: 10.1093/europace/eut398] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/11/2023] Open
Abstract
AIMS Pulmonary vein isolation (PVI) is an accepted treatment to relieve symptoms in patients with atrial fibrillation (AF). We studied 3 year outcome after PVI guided by duty-cycled multi-electrode radiofrequency (RF) ablation (pulmonary vein ablation catheter, PVAC) and provided comparative data to outcome after conventional PVI (CPVI) using mapping with irrigated, point-per-point RF ablation. METHODS AND RESULTS One hundred and sixty-one consecutive patients with symptomatic paroxysmal or persistent AF and minimal heart disease underwent PVI (PVAC, n = 79 vs. CPVI, n = 82). Follow-up (with symptom-guided rhythm monitoring) was truncated at 3 years in all patients. Success was defined as freedom of documented arrhythmia after a single procedure and without antiarrhythmic drug treatment (ADT). Baseline characteristics did not differ between both groups. At 3 years follow-up, single-procedure success without ADT was comparable between PVAC and CPVI (65% vs. 55%, P = NS). The majority of recurrences occurred during the first year (PVAC 79% vs. CPVI 70%, P = NS). The annual rate of very late recurrence (i.e. beyond 1 year) was similar in both groups (10.5% vs. 15%, P = NS). CONCLUSION At 3 years follow-up, outcome after PVAC-guided PVI is comparable to conventional isolation by irrigated point-by-point RF ablation. In both strategies, the majority of recurrences occurred in the first year of ablation.
Collapse
Affiliation(s)
- Y De Greef
- Department of Cardiology, Antwerp Cardiovascular Institute Middelheim, Lindendreef 1, 2020 Antwerpen, Belgium
| | - I Buysschaert
- Department of Cardiology, Antwerp Cardiovascular Institute Middelheim, Lindendreef 1, 2020 Antwerpen, Belgium
| | - B Schwagten
- Department of Cardiology, Antwerp Cardiovascular Institute Middelheim, Lindendreef 1, 2020 Antwerpen, Belgium
| | - D Stockman
- Department of Cardiology, Antwerp Cardiovascular Institute Middelheim, Lindendreef 1, 2020 Antwerpen, Belgium
| | - R Tavernier
- Department of Cardiology, Sint Jan Hospital Bruges, Belgium
| | - M Duytschaever
- Department of Cardiology, Sint Jan Hospital Bruges, Belgium Department of Cardiology, University Hospital of Ghent, Belgium
| |
Collapse
|
13
|
De Greef Y, Tavernier R, Duytschaever M. Sequelae After AF Ablation: Efficacy and Safety go Hand in Hand. Indian Pacing Electrophysiol J 2012; 12:171-9. [PMID: 22912537 PMCID: PMC3407409 DOI: 10.1016/s0972-6292(16)30523-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Although nowadays performed on a routine basis, catheter ablation of atrial fibrillation is associated with the potential for major complications. Improving the safety remains therefore an important challenge. This article summarizes the different types of complications associated with AF ablation grouping them into clinically overt major complications, subclinical injury and permanent injury. Furthermore, it describes the potential predictors for complications and highlights the dynamic interplay between efficacy and safety.
Collapse
Affiliation(s)
- Yves De Greef
- Department of Cardiology, Antwerp Cardiovascular Institute Middelheim, Belgium
| | - R Tavernier
- Department of Cardiology, Sint Jan Hospital Bruges, Belgium
| | - M Duytschaever
- Department of Cardiology, Sint Jan Hospital Bruges, Belgium
- University Hospital of Ghent, Belgium
| |
Collapse
|
14
|
Tavernier R, Duytschaever M. Cardioversion for atrial fibrillation in the real world: there is room for improvement. Europace 2012; 14:617-8. [DOI: 10.1093/europace/eus070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
15
|
De Greef Y, Tavernier R, Duytschaever M, Stockman D. Pulmonary vein isolation with the 30 and 35 mm high-density mesh ablator. Europace 2010; 12:1428-34. [DOI: 10.1093/europace/euq277] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
|
17
|
Tavernier R, Duytschaever M, Dossche K, Verleyen D, Van Den Brande F, De Greef Y, Vandekerckhove Y. Subacute implantable cardioverter defibrillator lead perforation: a potentially life-threatening event. Europace 2009; 11:966-7. [DOI: 10.1093/europace/eup100] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Potter TD, Tavernier R, Devos D, Beeumen KV, Duytschaever M. Predictors of Success After a First Circumferential Pulmonary Vein Isolation For Atrial Fibrillation. J Atr Fibrillation 2009; 1:161. [PMID: 28496618 DOI: 10.4022/jafib.161] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2009] [Revised: 02/19/2009] [Accepted: 03/17/2009] [Indexed: 11/10/2022]
Abstract
Background: To identify and characterise pre-procedural and procedural parameters which predict maintenance of sinus rhythm after a first circumferential pulmonary vein isolation (CPVI) for recurrent atrial fibrillation (AF). Methods: 100 patients (54±10 yrs) undergoing CARTO-guided CPVI for symptomatic drug refractory, paroxysmal or shortstanding persistent AF were studied. The endpoint was complete electrical isolation within the encircled regions. 3D left atrial (LA) volume was measured by CARTO geometry. Follow-up examinations (symptoms, ECG, 24-hour ECG recording) were performed at 1 and 3 months and every 3 months thereafter. Results: After the first CPVI, 71 patients (71%) were free of AF without antiarrhythmic drug therapy (follow up:28±11 months). The only independent and significant predictors for freedom of AF after the first CPVI were duration of AF history and 3D LA volume (p<0.05). However, a significant overlap in durations of AF history and 3D LA volumes between failures and successes was observed. Conclusions: (1) Using the "circumferential pulmonary vein isolation" approach, the first catheter ablation leads to resolution of arrhythmia in ≈ 70% of symptomatic AF patients. (2) Independent predictors for freedom of AF after initial CPVI are duration of AF history and 3D LA volume. (3) Due to considerable overlap between failures and successes, these parameters can not be used to identify patients who should not undergo CPVI or in whom an additional ablation beyond CPVI is required. On the other hand, our results do suggest that an ablation strategy early in the course of AF disease can influence successful outcome.
Collapse
Affiliation(s)
- T De Potter
- Department of Cardiology, University Hospital Ghent, Belgium (TDP, KVB, RS, RT, MD), Department of Radiology, University Hospital Ghent, Belgium (DD), Department of Cardiology, St-Jan Hospital, Brugge, Belgium (MD, RT)
| | - R Tavernier
- Department of Cardiology, University Hospital Ghent, Belgium (TDP, KVB, RS, RT, MD), Department of Radiology, University Hospital Ghent, Belgium (DD), Department of Cardiology, St-Jan Hospital, Brugge, Belgium (MD, RT)
| | - D Devos
- Department of Cardiology, University Hospital Ghent, Belgium (TDP, KVB, RS, RT, MD), Department of Radiology, University Hospital Ghent, Belgium (DD), Department of Cardiology, St-Jan Hospital, Brugge, Belgium (MD, RT)
| | - K Van Beeumen
- Department of Cardiology, University Hospital Ghent, Belgium (TDP, KVB, RS, RT, MD), Department of Radiology, University Hospital Ghent, Belgium (DD), Department of Cardiology, St-Jan Hospital, Brugge, Belgium (MD, RT)
| | - M Duytschaever
- Department of Cardiology, University Hospital Ghent, Belgium (TDP, KVB, RS, RT, MD), Department of Radiology, University Hospital Ghent, Belgium (DD), Department of Cardiology, St-Jan Hospital, Brugge, Belgium (MD, RT)
| |
Collapse
|
19
|
Duytschaever M, Tavernier R. What is needed for a good 'Decaf'? Europace 2009; 11:278-9. [DOI: 10.1093/europace/eup003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
20
|
De Clercq D, van Loon G, Tavernier R, Duchateau L, Deprez P. Atrial and Ventricular Electrical and Contractile Remodeling and Reverse Remodeling Owing to Short-Term Pacing-Induced Atrial Fibrillation in Horses. J Vet Intern Med 2008; 22:1353-9. [DOI: 10.1111/j.1939-1676.2008.0202.x] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
21
|
De Clercq D, van Loon G, Baert K, Tavernier R, Croubels S, De Backer P, Deprez P. Effects of an adapted intravenous amiodarone treatment protocol in horses with atrial fibrillation. Equine Vet J 2007; 39:344-9. [PMID: 17722727 DOI: 10.2746/042516407x182811] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
REASON FOR PERFORMING STUDY Good results have been obtained with a human amiodarone (AD) i.v. protocol in horses with chronic atrial fibrillation (AF) and a pharmacokinetic study is required for a specific i.v. amiodarone treatment protocol for horses. OBJECTIVES To study the efficacy of this pharmacokinetic based i.v. AD protocol in horses with chronic AF. METHODS Six horses with chronic AF were treated with an adapted AD infusion protocol. The protocol consisted of 2 phases with a loading dose followed by a maintenance infusion. In the first phase, horses received an infusion of 6.52 mg AD/kg bwt/h for 1 h followed by 1.1 mg/kg bwt/h for 47 h. In the second phase, horses received a second loading dose of 3.74 mg AD/kg bwt/h for 1 h followed by 1.31 mg/kg bwt/h for 47 h. Clinical signs were monitored, a surface ECG and an intra-atrial electrogram were recorded. AD treatment was discontinued when conversion or any side effects were observed. RESULTS Three of the 6 horses cardioverted successfully without side effects. The other 3 horses did not convert and showed adverse effects, including diarrhoea. In the latter, there were no important circulatory problems, but the diarrhoea continued for 10-14 days. The third horse had to be subjected to euthanasia because a concomitant Salmonella infection worsened the clinical signs. CONCLUSION The applied treatment protocol based upon pharmacokinetic data achieved clinically relevant concentrations of AD and desethylamiodarone. POTENTIAL RELEVANCE Intravenous AD has the potential to be an alternative pharmacological treatment for AF in horses, although AD may lead to adverse drug effects, particularly with cumulative dosing.
Collapse
Affiliation(s)
- D De Clercq
- Department of Large Animal Internal Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium
| | | | | | | | | | | | | |
Collapse
|
22
|
Kennergren C, Bucknall CA, Butter C, Charles R, Fuhrer J, Grosfeld M, Tavernier R, Morgado TB, Mortensen P, Paul V, Richter P, Schwartz T, Wellens F. Laser-assisted lead extraction: the European experience. ACTA ACUST UNITED AC 2007; 9:651-6. [PMID: 17597078 DOI: 10.1093/europace/eum098] [Citation(s) in RCA: 103] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
AIMS The aim of this study is to investigate the safety and effectiveness of Excimer laser-assisted lead extraction in Europe. The final European multi-centre study experience is presented. METHOD AND RESULTS The Excimer is a cool cutting laser (50 degrees C) with a wavelength of 308 nm. The energy is emitted from the tip of a flexible sheath and is absorbed by proteins and lipids, 64% of the energy is absorbed at a tissue depth of 0.06 mm. The sheath is positioned over the lead, and the fibrosis surrounding the lead is vaporized while advancing the sheath without damaging other leads. From August 1996 to March 2001, 383 leads (170 atrial, 213 ventricular) in 292 patients (mean age 61.6 years, range 13-96) were extracted at 14 European centres. Mean implantation time was 74 months (3-358). Most frequent indications were pocket infection (26%), non-functional leads (21%), patient morbidity (21%), septicaemia or endocarditis (14%), erosion (5%), and lead interference (8%). Median extraction time was 15 min (1-300). Complete extraction was achieved in 90.9% of the leads and partial extraction in 3.4%. Extraction failed in 5.7% of the leads. Major complications = perforations caused 10/22 (3.4/5.7%) of the failures. Most partially extracted patients were considered clinically successful, as only minor lead parts without clinical significance were left. Femoral non-laser technique was used to remove 8/12 of the non-complication failures. The total complication rate, including five minor complications (1.7%), was 5.1%. No in-hospital mortality occurred. CONCLUSION Pacing and implantable cardioverter-defibrillator leads can safely, effectively, and predictably be extracted. Open-heart extractions can be limited to special cases. The results indicate that the traditional policy of abandoning redundant leads, instead of removing them, may be obsolete in many patients.
Collapse
Affiliation(s)
- C Kennergren
- Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
De Sutter J, Tavernier R, De Bacquer D, De Buyzere M, Van de Veire NR, Jordaens L, Matthys K, Bernard D, Langlois M, De Backer G. Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants. Int J Cardiol 2006; 112:72-9. [PMID: 16316699 DOI: 10.1016/j.ijcard.2005.09.020] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/01/2005] [Revised: 08/24/2005] [Accepted: 09/18/2005] [Indexed: 11/17/2022]
Abstract
BACKGROUND The internal cardioverter defibrillator (ICD) is increasingly used to treat ventricular tachyarrhythmias in patients with coronary artery disease (CAD). The burden of coronary risk factors and inflammation is however not well studied in these high risk patients. STUDY AIMS The aim of the present study was to describe the prevalence of coronary risk factors (including lipid values) and inflammation (including high sensitive-C-reactive protein, hs-CRP) in patients with CAD and ICD implants. METHODS Baseline clinical characteristics and laboratory results of all eligible patients for the Cholesterol Lowering and Arrhythmias Recurrences after Internal Defibrillator Implantation trial (CLARIDI trial) were used. All patients had documented CAD, an ICD implant and were not yet treated with statins. Coronary risk factors, lipid values, glycated haemoglobin (HbA(1c)) and hs-CRP levels were determined. RESULTS In the 110 included patients (mean age 68+/-9 years, LVEF 40+/-17%, NYHA class II-III in 47%), a high prevalence of coronary risk factors was documented: current smoking in 18%, body mass index > or =30 kg/m(2) in 16%, blood pressure > or =140/90 mm Hg in 40%, history of diabetes in 12%, and HbA(1c) > or =6% in 16% of patients not known with diabetes. A total cholesterol >175 mg/dl was found in 76% of patients and an LDL cholesterol >100 mg/dl in 83%. Finally, median hs-CRP was 4.8 mg/l (interquartile range 2.5-13.9 mg/l). Hs-CRP values > or =2 mg/l were noted in 83% of all patients and in 68% of patients who had an ICD implant more than 6 months before inclusion. CONCLUSION In CAD patients with ICD implants, the burden of coronary risk factors is high, often unrecognized and/or under-treated. Persistent inflammation is found in the majority of these patients.
Collapse
Affiliation(s)
- J De Sutter
- Department of Cardiology, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
De Clercq D, van Loon G, Baert K, Tavernier R, Croubels S, De Backer P, Deprez P. Intravenous amiodarone treatment in horses with chronic atrial fibrillation. Vet J 2006; 172:129-34. [PMID: 15908245 DOI: 10.1016/j.tvjl.2005.04.001] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Six horses without underlying cardiac disease were presented because of atrial fibrillation of between 5 and 12 months duration. These horses received an intravenous amiodarone treatment of 5mg/kg/h for 1 h followed by 0.83mg/kg/h for 23h and subsequently 1.9mg/kg/h for 30h. During treatment, clinical signs were monitored and a surface ECG and an intra-atrial electrogram were recorded. Infusion was discontinued when sinus rhythm or side effects occurred. Four horses successfully cardioverted, of which one showed symptoms of hind limb weakness and weight shifting. Two horses did not cardiovert and showed similar side effects. In all horses, side effects disappeared within 6h after termination of treatment. Cardiac side effects, such as pro-arrhythmia, were not seen in any of the horses. Total bilirubin slightly increased in three horses and normalised within four days. It was concluded that amiodarone has the potential to treat naturally occurring chronic atrial fibrillation in horses, although further research is needed to refine the infusion protocol.
Collapse
Affiliation(s)
- D De Clercq
- Department of Large Animal Internal Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.
| | | | | | | | | | | | | |
Collapse
|
25
|
van Loon G, De Clercq D, Tavernier R, Amory H, Deprez P. Transient complete atrioventricular block following transvenous electrical cardioversion of atrial fibrillation in a horse. Vet J 2005; 170:124-7. [PMID: 15993796 DOI: 10.1016/j.tvjl.2004.08.013] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/19/2004] [Indexed: 11/27/2022]
Abstract
Transvenous electrical cardioversion was attempted in a horse with drug refractory atrial fibrillation. A temporary pacing catheter and two defibrillation catheters were inserted transvenously into the right ventricular apex, the right atrium and the pulmonary artery, respectively. Under general anaesthesia 100, 200, 300 and 360 J monophasic shocks were delivered between both defibrillation catheters but sinus rhythm could not be restored. Immediately after the 200, 300 and 360 J shock, transient third-degree atrioventricular block occurred for a period of, respectively, 15, 40 and 55 s. These periods of profound bradycardia were corrected by temporary right ventricular pacing until spontaneous conduction resumed. It is concluded that temporary right ventricular pacing should be available during electrical cardioversion of atrial fibrillation in horses.
Collapse
Affiliation(s)
- G van Loon
- Large Animal Internal Medicine, Ghent University, Salisburylaan 133, B-9820 Merelbeke, Belgium.
| | | | | | | | | |
Collapse
|
26
|
Tavernier R, Van Wassenhove E, Duytschaever M, Francois K, Stoffelen W, Berkhof M. P.3.8 Feasibility and follow-up of autocapture® with an epicardial ventricular lead in children and neonates. Europace 2003. [DOI: 10.1016/eupace/4.supplement_1.a47-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Affiliation(s)
- R. Tavernier
- Department of Cardiology, St. Jude Medical, Sylmar, CA, USA
| | | | | | - K. Francois
- Cardiac Surgery, St. Jude Medical, Sylmar, CA, USA
| | | | | |
Collapse
|
27
|
Abstract
BACKGROUND The understanding of the onset mechanisms of paroxysmal atrial fibrillation (AF) may help to develop preventive therapy. Specific heart rate (HR) patterns and autonomic changes immediately before the onset of paroxysmal AF are not fully investigated. We undertook the present study to assess HR and heart rate variability (HRV) changes before the onset of AF using 24-h Holter electrocardiographic analysis in patients without antiarrhythmic medication. METHODS AND RESULTS In 27 patients, 48 episodes of AF, lasting more than 30s and preceded by sinus rhythm for more than 1h were analysed. The hour preceding AF was divided in 5- and 30 min blocks. HR was also analysed in the last 15 beats. In 21% of the episodes, HR decreased >or=5% in the last 5 min (defined as deceleration); it increased >or=5% in 37% (defined as acceleration). HR, standard deviation (SD) and SD corrected for RR interval changed significantly in the last 5 min in the total group. Acceleration and deceleration were already visible over 30-min blocks in both these subgroups; changes in SD were only seen in the accelerators. The number of atrial premature beats (PACs) increased before AF, most clearly in the accelerators. Spectral HRV analysis revealed no additional information. CONCLUSIONS Changes in HR, SD, and an increased number of PACs herald AF from at least 30 min before onset, more pronounced in accelerators. Spectral HRV parameters are not useful to foresee AF onset. This has possible implications for device therapy.
Collapse
Affiliation(s)
- C Dimmer
- Department of Cardiology, University Hospital Ghent, Belgium
| | | | | | | | | |
Collapse
|
28
|
van Loon G, Fonteyne W, Rottiers H, Tavernier R, Deprez P. Implantation of a dual-chamber, rate-adaptive pacemaker in a horse with suspected sick sinus syndrome. Vet Rec 2002; 151:541-5. [PMID: 12448492 DOI: 10.1136/vr.151.18.541] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
A five-year-old gelding suffered syncope at the end of a period of exercise. A 24-hour electrocardiogram recording revealed intermittent pauses in the sinus rhythm of up to 10 seconds, indicating sinus node disease; the pauses occurred repeatedly, particularly after exercise. A dual-chamber, rate-adaptive pacemaker was successfully implanted, which prevented excessive postexercise bradycardia and syncope, and allowed the horse to return to work.
Collapse
Affiliation(s)
- G van Loon
- Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, Ghent University, Merelbeke, Belgium
| | | | | | | | | |
Collapse
|
29
|
Abstract
We describe the development and the different features of an experimental model of chronic atrial fibrillation (AF) in equines. In four healthy ponies a dual-chamber pacemaker, with an adapted pacemaker program, was implanted transvenously in the standing animal. This adapted pacemaker induced episodes of AF by delivering a 2s burst of electrical stimuli (42 Hz) as soon as sinus rhythm was detected. Simultaneous with a surface electrocardiogram, the intra-atrial electrogram could be recorded to determine the atrial electrogram morphology. Programmed electrical stimulation (PES) was used to determine the atrial effective refractory period (AERP) and the rate adaptation of the AERP, the sinus node recovery time (SNRT) and the corrected SNRT, AF vulnerability, AF cycle length and AF duration. This experimental AF model can be used to study the pathophysiology of chronic AF in equines.
Collapse
Affiliation(s)
- G Van Loon
- Department of Cardiology, University Hospital, Ghent University, Ghent, Belgium.
| | | | | | | | | | | |
Collapse
|
30
|
Loon G, Fonteyne W, Rottiers H, Tavernier R, Jordaens L, D'Hont L, Colpaert R, Clercq T, Deprez P. Dual-Chamber Pacemaker Implantation via the Cephalic Vein in Healthy Equids. J Vet Intern Med 2001. [DOI: 10.1111/j.1939-1676.2001.tb01592.x] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
31
|
van Loon G, Fonteyne W, Rottiers H, Tavernier R, Jordaens L, D'Hont L, Colpaert R, De Clercq T, Deprez P. Dual-chamber pacemaker implantation via the cephalic vein in healthy equids. J Vet Intern Med 2001; 15:564-71. [PMID: 11817062 DOI: 10.1892/0891-6640(2001)015<0564:dpivtc>2.3.co;2] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
The purpose of the present study was to develop a feasible and safe technique for dual-chamber pacemaker implantation in healthy horses. Implantation was performed in a standing, tranquilized horse and in ponies. Atrial and ventricular leads were transvenously inserted through the cephalic vein, and a subcutaneous pacemaker pocket was created between the lateral pectoral groove and the manubrium sterni in 6 equids. Positioning of each lead was guided by echocardiography and by measuring the electrical characteristics of the lead. The implantation procedure lasted about 4 hours in each animal and was well tolerated. In all animals, dual-chamber pacemaker function was obtained, and these results remained good throughout the follow-up period. At the time of implantation, atrial and ventricular sensing were between 2.1 and 7.2 mV and 7.8 and 16.8 mV, respectively, and atrial and ventricular pacing thresholds at 0.5 millisecond varied from 0.5 to 0.7 V and from 0.3 to 1.0 V, respectively. Six months after the implantation, sensing values varied from 2 to 10 mV for the atrial lead and from 2 to 16 mV for the ventricular lead, while pacing thresholds at 0.5 millisecond varied from less than 0.5 to 2.5 V for the right atrium and from less than 0.5 to 5.0 V for the right ventricle. Atrial lead dislodgment occurred in 2 animals, requiring insertion of a new lead. Ventricular lead dislodgment was not observed.
Collapse
Affiliation(s)
- G van Loon
- Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, University of Ghent, Merelbeke, Belgium.
| | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Abstract
AIMS The purpose of this study was to assess risk factors for sudden death after discharge from hospital for myocardial infarction in an era in which 50% of patients receive thrombolytic drugs. METHODS AND RESULTS We prospectively studied 708 consecutive survivors of myocardial infarction admitted to hospitals, which had registered their clinical, functional, and electrical parameters. A total of 83 patients died in the first 2 years (12%) after discharge. Sudden death was only observed in 12 patients. In multivariate analysis only NYHA class >I, and a filtered QRS duration > or =110 ms were important predictive variables for sudden death. A pre-defined high-risk group of 25 patients had no sudden death. When the strongest predictive variables in univariate analysis were combined to increase the positive predictive value for sudden death, we only achieved a maximal value of 27%. CONCLUSIONS In an unselected infarction population, the risk for sudden death is low in the first 2 years. Therefore, prediction and prophylactic intervention, such as defibrillator therapy become difficult. The event is related to cardiac dysfunction on admission, and with abnormalities in the filtered electrocardiogram.
Collapse
Affiliation(s)
- L Jordaens
- University Hospital of Ghent, Ghent, Belgium
| | | |
Collapse
|
33
|
|
34
|
Fonteyne W, Rottiers H, Tavernier R. Single centre experience with extraction of chronic implanted transvenous ICD leads: methods and results. Europace 2001. [DOI: 10.1016/eupace/2.supplement_1.a29-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
35
|
Tavernier R, Gevaert S, De Sutter J, De Clercq A, Rottiers H, Jordaens L, Fonteyne W. Long term results of cardioverter-defibrillator implantation in patients with right ventricular dysplasia and malignant ventricular tachyarrhythmias. Heart 2001; 85:53-6. [PMID: 11119463 PMCID: PMC1729567 DOI: 10.1136/heart.85.1.53] [Citation(s) in RCA: 68] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
OBJECTIVE To study the outcome of patients with arrhythmogenic right ventricular dysplasia treated with an implantable cardioverter-defibrillator (ICD) for ventricular tachyarrhythmias complicated by haemodynamic collapse. DESIGN Observational study. SETTING University hospital. PATIENTS Nine consecutive patients (eight male, one female; mean (SD) age, 36 (18) years) with arrhythmogenic right ventricular dysplasia presenting with ventricular tachycardia and haemodynamic collapse (n = 6) or ventricular fibrillation (n = 3), treated with an ICD. MAIN OUTCOME MEASURES Survival; numbers of and reasons for appropriate and inappropriate ICD interventions. RESULTS After a mean (SD) follow up of 32 (24) months, all patients were alive. Six patients received a median of 19 (range 2-306) appropriate ICD interventions for events detected in the ventricular tachycardia window; four received a median of 2 (range 1-19) appropriate ICD interventions for events detected in the ventricular fibrillation window. Inappropriate interventions were seen for sinus tachycardia (18 episodes in three patients), atrial fibrillation (three episodes in one patient), and for non-sustained polymorphic ventricular tachycardia (one episode in one patient). CONCLUSIONS Patients with arrhythmogenic right ventricular dysplasia and malignant ventricular arrhythmias have a high recurrence rate requiring appropriate ICD interventions, but they also often have inappropriate interventions. Programming the device is difficult because this population develops supraventricular and ventricular tachyarrhythmias with similar rates.
Collapse
Affiliation(s)
- R Tavernier
- Department of Cardiology, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium.
| | | | | | | | | | | | | |
Collapse
|
36
|
De Sutter J, Kazmierczak J, Fonteyne W, Tavernier R, Jordaens LJ. Factors determining long-term outcomes and survival in patients with coronary artery disease and ventricular tachyarrhythmias: a single center experience. Pacing Clin Electrophysiol 2000; 23:1947-52. [PMID: 11139964 DOI: 10.1111/j.1540-8159.2000.tb07059.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A Single-Center Experience. The influence, after ICD implantation, of concomitant CABG, angioplasty, and other antiischemic therapeutic interventions, like treatment with beta-blockers, on outcome and mortality of patients with VT or VF due to CAD remains uncertain. The univariate and multivariate risks of recurrence of ventricular arrhythmias requiring ICD interventions or death associated with baseline clinical and functional variables were studied in 160 consecutive patients with CAD of whom 30 underwent CABG or angioplasty at < or = 2 weeks before ICD implantation. ICD interventions occurred in 98 (61%) patients over a mean follow-up of 1,065 days. In univariate and multivariate analysis, VT as the presenting arrhythmia was the only clinical factor predictive of recurrences. Treatment with beta-blockers at hospital discharge reduced the probability of recurrences. Kaplan-Meier analysis confirmed the effect of beta-blockers (P < 0.005) and of VT as the presenting arrhythmia (P < 0.01). Overall mortality was 61% (29/160). In multivariate analysis a low ejection fraction (< or = 0.20) and omission of angiotensin-converting enzyme inhibitors at discharge were associated with excess mortality. In Kaplan-Meier analysis, a low ejection fraction (borderline between 0.30 and 0.21, significant < 0.21) was the single predictor of mortality. Revascularization by CABG or angioplasty had no influence on ventricular arrhythmia recurrences or survival. During long-term follow-up, VT as the presenting arrhythmia and the omission of beta-blocker therapy were associated with excess recurrences of ventricular arrhythmias after ICD implantation. In contrast, survival depended primarily on left ventricular function at discharge. Revascularization did not prevent recurrences of arrhythmias and had no significant effect on survival in the small group of patients who underwent CABG or angioplasty.
Collapse
Affiliation(s)
- J De Sutter
- Department of Cardiology, Ghent University Hospital, Ghent, Belgium
| | | | | | | | | |
Collapse
|
37
|
De Sutter J, De Bondt P, Van de Wiele C, Fonteyne W, Dierckx R, Clement D, Tavernier R. Prevalence of potential candidates for biventricular pacing among patients with known coronary artery disease: a prospective registry from a single center. Pacing Clin Electrophysiol 2000; 23:1718-21. [PMID: 11139908 DOI: 10.1111/j.1540-8159.2000.tb07003.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
New forms of ventricular pacing are increasingly studied as an option in the management of patients with heart failure. Coronary artery disease (CAD) is the most frequent cause of heart failure, and patients with complete left or right bundle branch block (LBBB and RBBB) and a reduced left ventricular ejection fraction (LVEF) are the best candidates for this new therapy. However, the prevalence of this clinical presentation is uncertain. During a 1-year period, 433 patients with documented CAD (mean age 64 +/- 10 years, 79% men) who were referred for myocardial perfusion imaging were prospectively studied. All patients underwent a 2-day stress-rest gated 99mTc-Tetrofosmin SPECT study with evaluation of resting LV enddiastolic (LVEDV) and endsystolic (LVESV) volumes and LVEF. The resting ECG was examined in all patients for the presence of complete LBBB or RBBB. Of the 433 patients with CAD 36 patients (8.3%) had LBBB (n = 14) or RBBB (n = 22) and a QRS width > 120 ms. These 36 patients were in general older and more frequently had diabetes and atrial fibrillation. Patients with LBBB or RBBB had a significantly lower LVEF (41 +/- 16% vs 48 +/- 14%, P < 0.01) and significantly higher LV volumes compared to patients without LBBB or RBBB (177 +/- 79 mL vs 131 +/- 53 mL, P < 0.001 for LVEDV and 116 +/- 76 mL vs 73 +/- 49 mL, P < 0.001 for LVESV). In total, 112/433 (26%) had an LVEF < or = 40%; 16 had also a LBBB or RBBB (3.7% of the whole population, 14% of the patients with a LVEF < or = 40%). Within the group of patients with a LVEF > or = 40%, patients with BBB had comparable LVEF (26 +/- 9% vs 30 +/- 8%, P = NS) but significantly higher LVEDV and LVESV (230 +/- 70 mL vs 190 +/- 64 mL, P < 0.05 for LVEDV and 170 +/- 65 mL vs 135 +/- 56 mL, P < 0.05 for LVESV). In this prospective registry 3.7% of all patients with known CAD had LBBB or RBBB in combination with a LVEF < or = 40%. This represented 14% of all patients with a LVEF > or = 40%. These limited numbers should be kept in mind when considering biventricular pacing as a new therapeutic options in patients with heart failure.
Collapse
Affiliation(s)
- J De Sutter
- Department of Cardiology, Ghent University Hospital, Ghent, Belgium.
| | | | | | | | | | | | | |
Collapse
|
38
|
Extramiana F, Tavernier R, Maison-Blanche P, Neyroud N, Jordaens L, Leenhardt A, Coumel P. [Ventricular repolarization and Holter monitoring. Effect of sympathetic blockage on the QT/RR ratio]. Arch Mal Coeur Vaiss 2000; 93:1277-83. [PMID: 11190455] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Circadian variations of the QT interval and its heart rate dependency have been established. However, the respective roles of the sympathetic and parasympathetic nervous systems in their regulation are still undetermined. Eighteen healthy volunteers (average age 39 +/- 7 years, 10 men) were recruited and selected randomly to receive either placebo or atenolol (100 mg/day). The treatments were crossed after 7 days. The rate dependency of the QT was assessed by day and by night by 24 hour Holter ECG monitoring. The effects of atenolol on the rate dependency of the QT interval depend on the time of day. During the daytime, the QT rate dependency was reduced by atenolol (0.180 (0.162:0.198) versus 0.216 (0.195:0.236) with placebo, p < 0.01) whereas during the night, the QT rate dependency was the same in both groups. Therefore, the betablocker is associated with an inversion of the daily modulation of the QT rate dependency. The daytime rate-dependency of the QT interval in decreased with betablocker therapy. This result suggests a direct or indirect influence of the sympathetic nervous system on the rate dependency of ventricular repolarisation.
Collapse
Affiliation(s)
- F Extramiana
- Hôpital Lariboisière, service de cardiologie, 2, rue Ambroise-Parè, 75010 Paris
| | | | | | | | | | | | | |
Collapse
|
39
|
Funck RC, Adamec R, Lurje L, Capucci A, Ritter P, Shekan D, Slegers LC, Tavernier R, Ishikawa T. Atrial overdriving is beneficial in patients with atrial arrhythmias: first results of the PROVE Study. Pacing Clin Electrophysiol 2000; 23:1891-3. [PMID: 11139951 DOI: 10.1111/j.1540-8159.2000.tb07046.x] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The AF Prevention by Overdriving (PROVE) trial is an ongoing prospective study of the effectiveness of atrial overdrive pacing combined with an Automatic Rest Rate function in the prevention of atrial arrhythmias. All patients who have received a Talent DR 213 pacemaker are eligible for enrollment into the study. After a 1-month monitoring period, the patients are divided into two groups. Group I includes patients with > or = 2 appropriate mode-switch (MS) episodes, or 1 MS episode of > or = 10 minutes, and/or > 300 atrial runs of > 5 beats/month. Group II includes all other patients. The number and duration of atrial arrhythmias are measured the pacemaker's Automatic Interpretation and Data Analysis software (AIDA). Patients' quality-of-life is measured by a validated functional status questionnaire. After having been grouped, the patients are randomly assigned, in a crossover design, to standard DDDR or overdrive pacing + Rest Rate, each programmed for a 3-month period. Preliminary results in 78 patients show a 34% reduction in the mean number of MS, and a mean 48% shortening of the overall duration of the episodes by overdrive pacing + Rest Rate, achieved by a mean 84% prevalence of atrial pacing. Overdrive pacing + Rest Rate was well tolerated and associated with a slight improvement in quality-of-life.
Collapse
Affiliation(s)
- R C Funck
- Philipps-University Marburg, Dept. of Cardiology, Baldingerstr., D-35033 Marburg, Germany.
| | | | | | | | | | | | | | | | | |
Collapse
|
40
|
van Loon G, Tavernier R, Duytschaever M, Fonteyne W, Deprez P, Jordaens L. Pacing induced sustained atrial fibrillation in a pony. Can J Vet Res 2000; 64:254-8. [PMID: 11041507 PMCID: PMC1189629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
A transvenous, screw-in electrode was implanted in the right atrium of a healthy pony and connected with an implantable pulse generator programmed to deliver bursts of electrical stimuli to the atrium. Initially, cessation of burst pacing resulted in short (less than 1 minute), self-terminating episodes of atrial fibrillation. As burst pacing continued, the episodes of induced atrial fibrillation became longer. After 3 weeks of continuous atrial pacing, atrial fibrillation became sustained (56 hours). This model of pacing induced atrial fibrillation can be used to study the mechanisms leading to atrial fibrillation, its perpetuation and therapy. Our preliminary observations support the concept that once atrial fibrillation starts, it sets up changes in the electrical characteristics of the atrium that favor its own perpetuation.
Collapse
Affiliation(s)
- G van Loon
- Department of Large Animal Internal Medicine, Faculty of Veterinary Medicine, University of Ghent, Merelbeke, Belgium.
| | | | | | | | | | | |
Collapse
|
41
|
De Sutter J, Tavernier R, De Buyzere M, Jordaens L, De Backer G. Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients. J Am Coll Cardiol 2000; 36:766-72. [PMID: 10987597 DOI: 10.1016/s0735-1097(00)00787-7] [Citation(s) in RCA: 98] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
OBJECTIVES To evaluate a possible effect of lipid lowering drugs on recurrences of ventricular arrhythmias (VA) after implantable cardioverter defibrillator (ICD) implantation. BACKGROUND In patients with coronary artery disease (CAD), lipid lowering drugs reduce total and sudden cardiac death. Because the mechanism is not completely understood, we studied whether these drugs have a favorable influence on the occurrence of life-threatening VA in patients with CAD and ICD implants. METHODS We conducted an observational study in 78 patients with CAD and life-threatening VA, treated with an ICD. After ICD implantation, 27 patients were on treatment with lipid lowering drugs (group I) and 51 were not (group II). Patients were studied for the following end points: recurrences of VA requiring ICD intervention, cardiac death and hospitalization. RESULTS After a mean follow-up of 490 +/- 319 days, 35 patients (45%) had recurrences of VA requiring ICD intervention. In multivariate analysis, the use of lipid lowering drugs (chi-square 6.33, p = 0.012) and poorly tolerated sustained monomorphic ventricular tachycardia as initial presentation (chi-square 4.84, p = 0.028) remained as independent predictors of recurrences of VA. Patients in groups I and II had similar baseline clinical characteristics, but patients in group I had a lower incidence of recurrences of VA (6/27 or 22% vs. 29/51 or 57%, p = 0.004) and of the combined end points of cardiac death and hospitalization (4/27 or 15% vs. 23/51 or 45%, p = 0.015) compared with patients in group II. CONCLUSIONS This is the first observation that the use of lipid lowering drugs is associated with a reduction of recurrences of VA in patients with CAD and ICD implants. These data require confirmation in a prospective randomized trial.
Collapse
Affiliation(s)
- J De Sutter
- Department of Cardiology, University Hospital Ghent, Belgium.
| | | | | | | | | |
Collapse
|
42
|
Kazmierczak J, Tavernier R, De Sutter J, Jordaens L. [Clinical evaluation of a dual chamber implantable cardioverter-defibrillator]. Pol Merkur Lekarski 2000; 9:522-6. [PMID: 11081315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
Abstract
Single-chamber ventricular cardioverter-defibrillator (ICD) has been shown to significantly reduce the incidence of sudden cardiac death due to malignant ventricular arrhythmias. However, inappropriate therapy due to supraventricular tachyarrhythmias (mainly atrial fibrillation) affects up to 34% of patients. Moreover, it has been estimated that up to 20% of ICD patients are in the need of physiological antibradycardia pacing. Use of dual-chamber ICD offers an atrial signal for better ability to discriminate atrial from ventricular tachyarrhythmias as well as a maintenance of AV synchrony, what may be of critical importance for patients with a compromised left ventricular function. In the present study we describe our preliminary clinical experience with a dual-chamber ICD's implanted in 20 patients. During the implantation and in-hospital testing, 95 induced VT/VF episodes were correctly diagnosed by ICD, as well as 28 induced FA episodes. Over a mean follow-up period of 10 +/- 6 months, 98 tachycardia episodes were recorded. All 76 VT/VF episodes were correctly diagnosed, as were 18 of 22 FA. Four FA episodes were diagnosed as VT/VF and treated by antitachycardia pacing in 2 cases and by shock in 2. Thus, sensitivity and specificity of VT/VF detection are 100% and 82% respectively. A dual-chamber ICD appears to improve discrimination of atrial from ventricular tachyarrhythmias without loss of sensitivity and to decrease occurrence of inappropriate therapy. AV synchrony, by improving the hemodynamic status of the patient (mainly in those with impaired left ventricular function), may demonstrate better survival and comfort of life.
Collapse
|
43
|
De Sutter J, Tavernier R, Van de Wiele C, Kazmierckzak J, De Buyzere M, Jordaens L, Clement DL, Dierckx RA. Infarct size and recurrence of ventricular arrhythmias after defibrillator implantation. Eur J Nucl Med 2000; 27:807-15. [PMID: 10952492 DOI: 10.1007/s002590000261] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
Infarct size as determined by perfusion imaging is an independent predictor of mortality after implantable cardioverter defibrillator (ICD) implantation in patients with coronary artery disease (CAD) and life-threatening ventricular arrhythmias (VA). However, its value as a predictor of VA recurrence and hospitalisation after ICD implantation is unknown. Therefore, the objective of this study was to evaluate whether infarct size as determined by perfusion imaging can help to identify patients who are at high risk for recurrence of VA and hospitalisation after ICD implantation. We studied 56 patients with CAD and life-threatening VA. Before ICD implantation, all patients underwent a uniform study protocol including a thallium-201 stress-redistribution perfusion study. A defect score as a measurement of infarct size was calculated using a 17-segment 5-point scoring system. Study endpoints during follow-up were documented episodes of appropriate anti-tachycardia pacing and/or shocks for VA and cardiac hospitalisation for electrical storm (defined as three or more appropriate ICD interventions within 24 h), heart failure or angina. After a mean follow-up of 470+/-308 days, 22 patients (39%) had recurrences of VA. In univariate analysis, predictors for recurrence were: (a) ventricular tachycardia (VT) as the initial presenting arrhythmia (86% vs 59% for patients without ICD therapy, P=0.04), (b) treatment with beta-blockers (36% vs 68%, P=0.03) and (c) a defect score (DS) > or = 20 (64% vs 32%, P=0.03). In multivariate analysis, VT as the presenting arrhythmia (chi2=5.51, P=0.02) and a DS > or = 20 (chi2=4.22, P=0.04) remained independent predictors. Cardiac hospitalisation was more frequent in patients with a DS > or = 20 (44% vs 13% for patients with DS < 20, P=0.015) and this was particularly due to more frequent hospitalisations for electrical storm (24% vs 3% for patients with DS < 20, P=0.037). The extent of scarring determined by perfusion imaging can separate patients with CAD into high- and low-risk groups for recurrence of VA and cardiac hospitalisation after ICD implantation.
Collapse
Affiliation(s)
- J De Sutter
- Department of Cardiology, University Hospital Gent, Belgium.
| | | | | | | | | | | | | | | |
Collapse
|
44
|
Tavernier R, Fonteyne W, Vandewalle V, de Sutter J, Gevaert S. Use of an implantable cardioverter defibrillator in a patient with two implanted neurostimulators for severe Parkinson's disease. Pacing Clin Electrophysiol 2000; 23:1057-9. [PMID: 10879397 DOI: 10.1111/j.1540-8159.2000.tb00899.x] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We report a patient with Parkinson's disease treated with two pectorally implanted neurostimulators (NSs) who presented with a life-threatening ventricular tachyarrhythmia in whom an abdominal ICD was implanted. Testing during implantation showed that the NS did not affect the bipolar sensing of the ICD, even when the NSs were set at a frequency of 130 pulses/s with an output of 5 V and pulse width of 0.21 ms in a bipolar and a unipolar configuration. The ICD shock, however, did affect both NSs: there was a reset to the output Off state and there was a reset of the electrode polarities.
Collapse
Affiliation(s)
- R Tavernier
- Department of Cardiology, University Hospital Ghent, Belgium.
| | | | | | | | | |
Collapse
|
45
|
Pruvot E, Thonet G, Vesin JM, van-Melle G, Seidl K, Schmidinger H, Brachmann J, Jung W, Hoffmann E, Tavernier R, Block M, Podczeck A, Fromer M. Heart rate dynamics at the onset of ventricular tachyarrhythmias as retrieved from implantable cardioverter-defibrillators in patients with coronary artery disease. Circulation 2000; 101:2398-404. [PMID: 10821817 DOI: 10.1161/01.cir.101.20.2398] [Citation(s) in RCA: 73] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND The recent availability of implantable cardioverter-defibrillators (ICDs) that record 1024 R-R intervals preceding a ventricular tachyarrhythmia (VTA) provides a unique opportunity to analyze heart rate variability (HRV) before the onset of VTA. METHODS AND RESULTS Fifty-eight post-myocardial infarction patients with an implanted ICD for recurrent VTA provided 2 sets of 98 heart rate recordings in sinus rhythm: (1) before a VTA and (2) during control conditions. Three subgroups were considered according to the antiarrhythmic (AA) drug regimen. A state of sympathoexcitation was suggested by the significant reduction in HRV before VTA onset compared with control conditions. beta-Blockers and dl-sotalol enhanced HRV in control recordings; nevertheless, HRV declined before VTA independent of AA drugs. A gradual increase in heart rate and decrease in sinus arrhythmia at VTA onset were specific findings of patients who received dl-sotalol. CONCLUSIONS The peculiar heart rate dynamics observed before VTA onset are suggestive of a state of sympathoexcitation that is independent of AA drugs.
Collapse
Affiliation(s)
- E Pruvot
- Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Tavernier R, De Pauw M, Trouerbach J. Incessant automatic atrial tachycardia: a reversible cause of tachycardiomyopathy. Acta Cardiol 1999; 54:227-9. [PMID: 10511899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
Abstract
We describe the case of a 23-year-old man with incessant atrial tachycardia complicated with tachycardiomyopathy. Transseptal ablation of the arrhythmia focus, located between the ostia of the left and right inferior vena pulmonalis, resulted in a restoration of normal sinus rhythm and a complete regression of the signs of tachycardiomyopathy.
Collapse
Affiliation(s)
- R Tavernier
- Department of Cardiology, University Hospital Ghent, Belgium.
| | | | | |
Collapse
|
47
|
Jordaens L, Tavernier R. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death]. J Med Liban 1999; 47:181-9. [PMID: 10550944] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/14/2023]
|
48
|
De Sutter J, Tavernier R, Van De Wiele C, De Backer J, Kazmierczak J, De Backer G, Dierckx R, Jordaens L. QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life threatening ventricular arrhythmias. Heart 1999; 81:533-8. [PMID: 10212174 PMCID: PMC1729042 DOI: 10.1136/hrt.81.5.533] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVE To relate QT parameters to infarct size and inducibility during electrophysiological studies. DESIGN Analysis of a prospective register. SETTING University hospital. PATIENTS 64 patients with coronary artery disease and documented life threatening ventricular arrhythmias. INTERVENTIONS Measurements of QT-max, QTc-max, and QT dispersion (QT-d) on a simultaneous 12 lead ECG (50 mm/s). Estimation of myocardial infarct size with radionuclide left ventricular ejection fraction (LVEF), echocardiography (left ventricular end diastolic diameter, LVEDD), and a defect score based on a quantitative stress redistribution 201-thallium perfusion study. Electrophysiological study to assess inducibility. RESULTS Mean (SD) QT parameters were: QT-max 440 (50) ms, QTc-max 475 (46) ms, and QT-d 47 (20) ms. Mean (SD) estimates of infarct size were: LVEF 34 (13)%, LVEDD 61 (9) mm, and defect score 18 (11). There was no significant correlation between any index of infarct size and QT parameters. QT parameters were not significantly different between patients with inducible (n = 57) and non-inducible arrhythmias (n = 7) (QT-max: 416 (30) v 443 (51) ms, p = 0.18; QTc-max 485 (34) v 473 (47) ms, p = 0.34; QT-d 47 (12) v 47 (21) ms, p = 0.73). Non-inducible patients had a significant lower defect score: 8 (9) v 19 (11), p = 0.02, but comparable LVEF: 38 (12)% v 34 (12)%, p = 0.58, and LVEDD: 54 (10) v 61 (8) mm, p = 0.13. CONCLUSIONS QT parameters are not influenced by infarct size and do not predict inducibility during electrophysiological study in patients with coronary artery disease and malignant ventricular arrhythmias. In contrast, the amount of scar tissue determined by perfusion imaging is strongly correlated with inducibility.
Collapse
Affiliation(s)
- J De Sutter
- Department of Cardiology, University Hospital Gent, De Pintelaan 185, 9000 Gent, Belgium
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Tavernier R, Hutse W, Jordaens L. The combination of risk factors for sudden death in a resuscitated elderly patient with an exceptional cause of left ventricular hypertrophy. Acta Cardiol 1999; 54:41-3. [PMID: 10214475] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/12/2023]
Abstract
The work-up of a previously asymptomatic 72-year-old man presenting with sudden cardiac death revealed a coarctation of the aorta as the cause of arterial hypertension, severe left ventricular hypertrophy, in combination with coronary artery disease with an apical myocardial infarction, severe autonomic dysfunction, and AV-nodal reentrant tachycardia. All these elements and their complex, probably synergistic interactions might have been involved in the development of sudden cardiac death.
Collapse
Affiliation(s)
- R Tavernier
- Department of Cardiology, University Hospital Ghent, Belgium.
| | | | | |
Collapse
|
50
|
Abstract
Internal cardioverter-defibrillator implantation can be performed under local or general anaesthesia. Whether the technique of general anaesthesia influences the defibrillation threshold remains a matter of debate. We therefore compared, in a prospective, randomised clinical study, the effect of intravenous anaesthesia using propofol with inhalational anaesthesia using isoflurane on the defibrillation threshold in 68 patients scheduled for transvenous single-lead internal cardioverter-defibrillator implantation. Defibrillation threshold was measured at implantation and at device testing 1 week and 1 month after implantation. Patients acted as their own controls. Neither the anaesthetic technique nor the duration of anaesthesia was associated with significant changes in the defibrillation threshold. We conclude that in this group of high-risk patients, both types of anaesthesia are acceptable techniques for internal cardioverter-defibrillator implantation and testing.
Collapse
Affiliation(s)
- A Moerman
- Department of Anaesthesia, University Hospital, Gent, Belgium
| | | | | | | | | | | |
Collapse
|